Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 513 results for "Shionogi"

Lupin buys 21 drugs from Japan's Shionogi to expand its generic portfolio
International Business Times India

Lupin Buys 21 Generic Brands from Japan's Shionogi

Indian drugmaker Lupin announces that it willbuy a portfolio of 21 drugs from Japan's Shionogi & Co Ltd for US$150 million.The portfolio will be transferred to Lupin on 31 December, subject to regulatory approvals and certain closing conditions. ... PharmaAsia, 2 weeks ago
Lupin to acquire 21 brands in Japan, 3 weeks ago

19 images for Shionogi

Business Standard, 3 weeks ago
Pharma Letter, 3 weeks ago
Business Standard India, 3 weeks ago
Money Control, 3 weeks ago
International Business Times India, 3 weeks ago
United News of India, 3 weeks ago
Scrip Intelligence, 3 weeks ago
Reuters, 3 weeks ago
Sify, 3 weeks ago, 3 weeks ago

Lupin's subsidiary enters into agreement with Shionogi & Co.

The article below represents a preview only and is not meant for reuse or republishing. India, Aug. 2 -- Pharma Major Lupin Limited has said that its Japanese subsidiary Kyowa Pharmaceutical Industry Co., Ltd. has entered into a strategic asset ...
 HT Syndication3 weeks ago Top 14 stocks in focus: Lupin, Tech Mahindra, IndiGo  India Infoline3 weeks ago

Investment strategies: 2 'must have' stocks in your portfolio

- By Bank of America Merrill Lynch reiterates buy call on Lupin with target at Rs 1950 per share as Shionogi portfolio acquisition marks entry into Japanese
 Moneycontrol.com3 weeks ago

Lupin expands Japan business with Rs 1,000 crore buy

Lupin has acquired the branded drug portfolio of Japanese pharma company Shionogi for about Rs 1,000 crore, expanding its presence in the market. Japan accounts for about 10 per cent of Lupin's revenue and is its third biggest market after the US ...
 Business Standard India3 weeks ago

Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brands

MUMBAI: Lupin, India's third-largest drugmaker, is in talks with Japan's Astellas and Shionogi to buy the off-patent medicine brands they have separately put on the block, two people aware of the development said. The basket of drugs that Astellas ...
 Economic Times1 month ago Deals Buzz: Fosun to buy Gland Pharma for $1.3 billion  Livemint.com1 month ago
Nikkei Asian Review

Japanese firms eye sale of patent-expired drugs to fund new blockbusters

Astellas Pharma and Shionogi are looking to sell branded drugs that have seen patents expire in Japan in a play to take the funds and invest in newer therapies or business lines, Nikkei Asian Review reports. For Osaka-based Shionogi, the news ...
 FiercePharma1 month ago Japanese drugmakers seek to unload off-patent brands  Nikkei Asian Review1 month ago

BRIEF-Shionogi & Co Ltd adjusts conversion price of 2019 due Euro Yen - denominated convertible bonds with warrants to 4,167.5 yen

June 23 Shionogi & Co Ltd : * Says it adjusts conversion price of 2019 due Euro Yen - denominated convertible bonds with warrants to 4,167.5 yen from 4,177.6 yen, effective from April 1 Source text in Japanese: Further ...
 Reuters UK2 months ago

Milner Therapeutics Institute Signs New Partnership with Japan's Shionogi

The Milner Therapeutics Consortium (Milner), the outreach programme of the Milner Therapeutics Institute, announces Shionogi as a new partner joining the consortium. Dr Takeshi Shiota, senior vice president, Pharmaceutical Research Division at ...
 CPhI.cn2 months ago Charles River Announces Partnership With  BioSpace2 weeks ago CHARLES RIVER LABORATORIES INTL : Announces Partnership with the Milner Therapeutics Institute and Consortium  4 Traders2 weeks ago Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium  Minyanville2 weeks ago

LUPIN : buys 21 branded products from Shionogi for $ 150 mn

India's third largest drug maker Lupin Ltd buys a portfolio of 21 generic brands from Shionogi & Co. Ltd, based on Osaka for $ 150 mn (Rs.10.08 billion) to boost its presence in the world's second biggest pharmaceutical market space. The acquisition ...
 4 Traders3 weeks ago Lupin buys 21 branded products from Shionogi for $ 150 mn [DealCurry (India)]  Pharmacy Choice3 weeks ago

SHIONOGI & CO LTD : quaterly earnings release

The company will report its earnings for Q1 2017 on 08/01/2016. Generally, the company reports earnings better than estimates. In recent months, the 11 analysts from Thomson Reuters consensus have not revised their
 4 Traders1 month ago SHIONOGI : Studies in the Area of beta-Lactams Reported from Shionogi & Co. Ltd. (Stability of Novel Siderophore Cephalosporin S-649266 against Clinically...  4 Traders1 month ago SHIONOGI : Report Summarizes Antisense Technology Study Findings from Shionogi & Co. Ltd. (Comparative Characterization of Hepatic Distribution and mRNA...  4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less